nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—DRD2—Gilles de la Tourette syndrome	0.748	1	CbGaD
Norepinephrine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00739	0.107	CbGeAlD
Norepinephrine—SLC18A1—nervous system—Gilles de la Tourette syndrome	0.00479	0.0694	CbGeAlD
Norepinephrine—SLC18A1—central nervous system—Gilles de la Tourette syndrome	0.00462	0.0669	CbGeAlD
Norepinephrine—SLC18A1—brain—Gilles de la Tourette syndrome	0.00366	0.0531	CbGeAlD
Norepinephrine—PAH—nervous system—Gilles de la Tourette syndrome	0.00344	0.0498	CbGeAlD
Norepinephrine—PAH—central nervous system—Gilles de la Tourette syndrome	0.00331	0.048	CbGeAlD
Norepinephrine—PAH—brain—Gilles de la Tourette syndrome	0.00263	0.0381	CbGeAlD
Norepinephrine—SLC18A2—midbrain—Gilles de la Tourette syndrome	0.00186	0.027	CbGeAlD
Norepinephrine—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00155	0.0224	CbGeAlD
Norepinephrine—SLC18A2—nervous system—Gilles de la Tourette syndrome	0.00153	0.0222	CbGeAlD
Norepinephrine—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00151	0.0219	CbGeAlD
Norepinephrine—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00149	0.0216	CbGeAlD
Norepinephrine—SLC18A2—central nervous system—Gilles de la Tourette syndrome	0.00147	0.0214	CbGeAlD
Norepinephrine—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00146	0.0211	CbGeAlD
Norepinephrine—L-DOPA—DRD4—Gilles de la Tourette syndrome	0.00135	0.182	CrCbGaD
Norepinephrine—Dopamine—DRD4—Gilles de la Tourette syndrome	0.00125	0.169	CrCbGaD
Norepinephrine—ADRA1B—brain—Gilles de la Tourette syndrome	0.00118	0.0171	CbGeAlD
Norepinephrine—SLC18A2—brain—Gilles de la Tourette syndrome	0.00117	0.017	CbGeAlD
Norepinephrine—L-DOPA—DRD3—Gilles de la Tourette syndrome	0.00116	0.157	CrCbGaD
Norepinephrine—ADRA1D—brain—Gilles de la Tourette syndrome	0.00116	0.0168	CbGeAlD
Norepinephrine—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.00114	0.0165	CbGeAlD
Norepinephrine—ADRB1—nervous system—Gilles de la Tourette syndrome	0.0011	0.0159	CbGeAlD
Norepinephrine—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.0011	0.0159	CbGeAlD
Norepinephrine—SLC22A3—nervous system—Gilles de la Tourette syndrome	0.00109	0.0158	CbGeAlD
Norepinephrine—Dopamine—DRD3—Gilles de la Tourette syndrome	0.00108	0.146	CrCbGaD
Norepinephrine—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.00106	0.0153	CbGeAlD
Norepinephrine—SLC22A3—central nervous system—Gilles de la Tourette syndrome	0.00105	0.0152	CbGeAlD
Norepinephrine—DRD2—midbrain—Gilles de la Tourette syndrome	0.00104	0.015	CbGeAlD
Norepinephrine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.00101	0.0146	CbGeAlD
Norepinephrine—Dopamine—SLC6A3—Gilles de la Tourette syndrome	0.00101	0.136	CrCbGaD
Norepinephrine—SLC22A5—midbrain—Gilles de la Tourette syndrome	0.000965	0.014	CbGeAlD
Norepinephrine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000935	0.0135	CbGeAlD
Norepinephrine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.0009	0.013	CbGeAlD
Norepinephrine—SLC22A1—brain—Gilles de la Tourette syndrome	0.000872	0.0126	CbGeAlD
Norepinephrine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000869	0.0126	CbGeAlD
Norepinephrine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000852	0.0123	CbGeAlD
Norepinephrine—ADRB1—brain—Gilles de la Tourette syndrome	0.00084	0.0122	CbGeAlD
Norepinephrine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000837	0.0121	CbGeAlD
Norepinephrine—SLC22A3—brain—Gilles de la Tourette syndrome	0.000834	0.0121	CbGeAlD
Norepinephrine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000828	0.012	CbGeAlD
Norepinephrine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.00082	0.0119	CbGeAlD
Norepinephrine—L-DOPA—DRD2—Gilles de la Tourette syndrome	0.000804	0.109	CrCbGaD
Norepinephrine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000804	0.0116	CbGeAlD
Norepinephrine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000797	0.0115	CbGeAlD
Norepinephrine—Dopamine—DRD2—Gilles de la Tourette syndrome	0.000748	0.101	CrCbGaD
Norepinephrine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000714	0.0103	CbGeAlD
Norepinephrine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000664	0.00962	CbGeAlD
Norepinephrine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000661	0.00957	CbGeAlD
Norepinephrine—DRD2—brain—Gilles de la Tourette syndrome	0.000651	0.00943	CbGeAlD
Norepinephrine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000636	0.00921	CbGeAlD
Norepinephrine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000633	0.00917	CbGeAlD
Norepinephrine—SLC22A5—brain—Gilles de la Tourette syndrome	0.000606	0.00878	CbGeAlD
Norepinephrine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000505	0.00732	CbGeAlD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000184	0.00105	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000182	0.00104	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000181	0.00103	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00018	0.00102	CbGpPWpGaD
Norepinephrine—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00018	0.00102	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000179	0.00102	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000177	0.001	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.000177	0.001	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000175	0.000995	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000172	0.000979	CbGpPWpGaD
Norepinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00017	0.000968	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00017	0.000966	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000169	0.000964	CbGpPWpGaD
Norepinephrine—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000168	0.000958	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000168	0.000957	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000168	0.000954	CbGpPWpGaD
Norepinephrine—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000167	0.000952	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000167	0.000951	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000167	0.000948	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000165	0.000936	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000164	0.000936	CbGpPWpGaD
Norepinephrine—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000163	0.00093	CbGpPWpGaD
Norepinephrine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000162	0.000921	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000159	0.000907	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000158	0.0009	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000158	0.000898	CbGpPWpGaD
Norepinephrine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000156	0.000889	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000156	0.000887	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000156	0.000886	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000155	0.00088	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000153	0.000872	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000153	0.000872	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000153	0.000871	CbGpPWpGaD
Norepinephrine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000152	0.000863	CbGpPWpGaD
Norepinephrine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000152	0.000863	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000151	0.000861	CbGpPWpGaD
Norepinephrine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000151	0.000858	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000151	0.000857	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00015	0.000856	CbGpPWpGaD
Norepinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00015	0.000851	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000147	0.000839	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000146	0.000832	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000146	0.000831	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000145	0.000826	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000144	0.00082	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000143	0.000815	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000143	0.000812	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000143	0.000811	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000141	0.000802	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000141	0.000802	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00014	0.000796	CbGpPWpGaD
Norepinephrine—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000139	0.00079	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000136	0.000775	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000136	0.000774	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000136	0.000772	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000134	0.000761	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000133	0.000759	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000133	0.000758	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000131	0.000747	CbGpPWpGaD
Norepinephrine—SLC22A3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000131	0.000746	CbGpPWpGaD
Norepinephrine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000131	0.000744	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00013	0.000739	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000129	0.000737	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000129	0.000736	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000129	0.000736	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000129	0.000734	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000126	0.000719	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000125	0.000712	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000124	0.000706	CbGpPWpGaD
Norepinephrine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000123	0.000702	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000121	0.00069	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00012	0.000685	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00012	0.000684	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00012	0.000682	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000119	0.000675	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000118	0.00067	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000118	0.00067	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000117	0.000664	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000117	0.000664	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000117	0.000663	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000116	0.000662	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000116	0.000657	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000115	0.000656	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000115	0.000656	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000112	0.000639	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000112	0.000638	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000111	0.00063	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000111	0.00063	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000111	0.000629	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00011	0.000628	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.000624	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000109	0.00062	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000109	0.00062	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000109	0.000619	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000108	0.000616	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000108	0.000613	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000107	0.000611	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000107	0.000611	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000107	0.000611	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000105	0.000597	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000104	0.000595	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000103	0.000587	CbGpPWpGaD
Norepinephrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000102	0.000581	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000102	0.00058	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000102	0.00058	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000102	0.000578	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000101	0.000574	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0001	0.000569	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0001	0.000569	CbGpPWpGaD
Norepinephrine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.89e-05	0.000563	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.89e-05	0.000563	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.87e-05	0.000562	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.82e-05	0.000559	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	9.53e-05	0.000542	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	9.53e-05	0.000542	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.49e-05	0.00054	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.34e-05	0.000532	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.19e-05	0.000523	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	9.12e-05	0.000519	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.88e-05	0.000505	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.86e-05	0.000504	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	8.86e-05	0.000504	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	8.75e-05	0.000498	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.48e-05	0.000482	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.43e-05	0.00048	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	8.25e-05	0.000469	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	8.22e-05	0.000468	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.17e-05	0.000465	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.69e-05	0.000437	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	7.67e-05	0.000436	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.61e-05	0.000433	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.59e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.53e-05	0.000428	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.52e-05	0.000428	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.32e-05	0.000416	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.31e-05	0.000416	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.11e-05	0.000405	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7e-05	0.000398	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.86e-05	0.00039	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.83e-05	0.000389	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.81e-05	0.000387	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.79e-05	0.000387	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.71e-05	0.000382	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.66e-05	0.000379	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.64e-05	0.000378	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.63e-05	0.000378	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.6e-05	0.000375	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.51e-05	0.000371	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.45e-05	0.000367	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.35e-05	0.000361	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.25e-05	0.000355	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.23e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.22e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.2e-05	0.000353	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.2e-05	0.000353	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.18e-05	0.000352	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.17e-05	0.000351	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.16e-05	0.000351	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.14e-05	0.00035	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.09e-05	0.000347	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.07e-05	0.000345	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.06e-05	0.000345	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.04e-05	0.000344	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.02e-05	0.000342	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.99e-05	0.000341	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.91e-05	0.000336	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.78e-05	0.000329	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.76e-05	0.000328	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.76e-05	0.000328	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.74e-05	0.000327	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.67e-05	0.000323	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.65e-05	0.000321	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.00032	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.6e-05	0.000319	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.59e-05	0.000318	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.59e-05	0.000318	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.58e-05	0.000318	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.55e-05	0.000316	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.51e-05	0.000313	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.51e-05	0.000313	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.39e-05	0.000306	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.23e-05	0.000298	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.21e-05	0.000297	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.15e-05	0.000293	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.13e-05	0.000292	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.08e-05	0.000289	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.04e-05	0.000287	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.02e-05	0.000286	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5e-05	0.000285	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.89e-05	0.000278	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	4.83e-05	0.000275	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.77e-05	0.000271	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.68e-05	0.000266	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.66e-05	0.000265	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.56e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.54e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.34e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.33e-05	0.000246	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.3e-05	0.000245	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.25e-05	0.000242	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.23e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.04e-05	0.00023	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.02e-05	0.000229	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.96e-05	0.000225	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000224	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.93e-05	0.000223	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.92e-05	0.000223	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.91e-05	0.000222	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.86e-05	0.00022	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.68e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.65e-05	0.000208	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.65e-05	0.000208	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.65e-05	0.000208	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.64e-05	0.000207	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.6e-05	0.000205	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.59e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.54e-05	0.000201	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.51e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.49e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.4e-05	0.000194	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.35e-05	0.000191	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.33e-05	0.000189	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.31e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.3e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.3e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.27e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.25e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.25e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.19e-05	0.000182	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.09e-05	0.000176	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.08e-05	0.000175	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.03e-05	0.000172	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3e-05	0.000171	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.98e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.96e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.89e-05	0.000164	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.77e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.69e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.68e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.56e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.5e-05	0.000142	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000133	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.31e-05	0.000131	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.00013	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.16e-05	0.000123	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.12e-05	0.000121	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.96e-05	0.000111	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.89e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.75e-05	9.97e-05	CbGpPWpGaD
